全文获取类型
收费全文 | 5729篇 |
免费 | 371篇 |
出版年
2022年 | 25篇 |
2021年 | 60篇 |
2020年 | 43篇 |
2019年 | 40篇 |
2018年 | 93篇 |
2017年 | 99篇 |
2016年 | 156篇 |
2015年 | 285篇 |
2014年 | 293篇 |
2013年 | 383篇 |
2012年 | 462篇 |
2011年 | 406篇 |
2010年 | 242篇 |
2009年 | 195篇 |
2008年 | 344篇 |
2007年 | 345篇 |
2006年 | 297篇 |
2005年 | 271篇 |
2004年 | 244篇 |
2003年 | 243篇 |
2002年 | 259篇 |
2001年 | 92篇 |
2000年 | 95篇 |
1999年 | 73篇 |
1998年 | 43篇 |
1997年 | 29篇 |
1996年 | 28篇 |
1995年 | 33篇 |
1994年 | 37篇 |
1993年 | 31篇 |
1992年 | 48篇 |
1991年 | 54篇 |
1990年 | 53篇 |
1989年 | 46篇 |
1988年 | 41篇 |
1987年 | 54篇 |
1986年 | 35篇 |
1985年 | 43篇 |
1984年 | 51篇 |
1983年 | 33篇 |
1982年 | 21篇 |
1981年 | 28篇 |
1980年 | 24篇 |
1979年 | 21篇 |
1978年 | 24篇 |
1974年 | 22篇 |
1973年 | 36篇 |
1972年 | 24篇 |
1971年 | 23篇 |
1970年 | 19篇 |
排序方式: 共有6100条查询结果,搜索用时 15 毫秒
171.
Silvia Maioli Ann B?vner Zeina Ali Maura Heverin Muhammad-Al-Mustafa Ismail Elena Puerta Maria Olin Ahmed Saeed Marjan Shafaati Paolo Parini Angel Cedazo-Minguez Ingemar Bj?rkhem 《PloS one》2013,8(7)
We previously described a heterozygous mouse model overexpressing human HA-tagged 24S-hydroxylase (CYP46A1) utilizing a ubiquitous expression vector. In this study, we generated homozygotes of these mice with circulating levels of 24OH 30–60% higher than the heterozygotes. Female homozygous CYP46A1 transgenic mice, aged 15 months, showed an improvement in spatial memory in the Morris water maze test as compared to the wild type mice. The levels of N-Methyl-D-Aspartate receptor 1, phosphorylated-N-Methyl-D-Aspartate receptor 2A, postsynaptic density 95, synapsin-1 and synapthophysin were significantly increased in the hippocampus of the CYP46A1 transgenic mice as compared to the controls. The levels of lanosterol in the brain of the CYP46A1 transgenic mice were significantly increased, consistent with a higher synthesis of cholesterol. Our results are discussed in relation to the hypothesis that the flux in the mevalonate pathway in the brain is of importance in cognitive functions. 相似文献
172.
Mette Munk Jensen Kamille Dumong Erichsen Camilla Bardram Johnbeck Fredrik Bj?rkling Jacob Madsen Michael Bzorek Peter Buhl Jensen Liselotte H?jgaard Maxwell Sehested Andreas Kj?r 《PloS one》2013,8(1)
Introduction
APO866 is a new anti-tumor compound inhibiting nicotinamide phosphoribosyltransferase (NAMPT). APO866 has an anti-tumor effect in several pre-clinical tumor models and is currently in several clinical phase II studies. 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) is a tracer used to assess cell proliferation in vivo. The aim of this study was non-invasively to study effect of APO866 treatment on [18F]FLT and 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake.Methods
In vivo uptake of [18F]FLT and [18F]FDG in human ovary cancer xenografts in mice (A2780) was studied at various time points after APO866 treatment. Baseline [18F]FLT or [18F]FDG scans were made before treatment and repeated after 24 hours, 48 hours and 7 days. Tumor volume was followed with computed tomography (CT). Tracer uptake was quantified using small animal PET/CT. One hour after iv injection of tracer, static PET scans were performed. Imaging results were compared with Ki67 immunohistochemistry.Results
Tumors treated with APO866 had volumes that were 114% (24 h), 128% (48 h) and 130% (Day 7) relative to baseline volumes at Day 0. In the control group tumor volumes were 118% (24 h), 145% (48 h) and 339% (Day 7) relative to baseline volumes Day 0. Tumor volume between the treatment and control group was significantly different at Day 7 (P = 0.001). Compared to baseline, [18F]FLT SUVmax was significantly different at 24 h (P<0.001), 48 h (P<0.001) and Day 7 (P<0.001) in the APO866 group. Compared to baseline, [18F]FDG SUVmax was significantly different at Day 7 (P = 0.005) in the APO866 group.Conclusions
APO866 treatment caused a significant decrease in [18F]FLT uptake 24 and 48 hours after treatment initiation. The early reductions in tumor cell proliferation preceded decrease in tumor volume. The results show the possibility to use [18F]FLT and [18F]FDG to image treatment effect early following treatment with APO866 in future clinical studies. 相似文献173.
Shashank Gupta Regine Utoft Henrik Hasseldam Anja Schmidt-Christensen Tine Dahlbaek Hannibal Lisbeth Hansen Nina Fransén-Pettersson Noopur Agarwal-Gupta Bj?rn Rozell ?sa Andersson Dan Holmberg 《PloS one》2013,8(10)
Multiple Sclerosis (MS) is a progressive autoimmune inflammatory and demyelinating disease of the central nervous system (CNS). T cells play a key role in the progression of neuroinflammation in MS and also in the experimental autoimmune encephalomyelitis (EAE) animal models for the disease. A technology for quantitative and 3 dimensional (3D) spatial assessment of inflammation in this and other CNS inflammatory conditions is much needed. Here we present a procedure for 3D spatial assessment and global quantification of the development of neuroinflammation based on Optical Projection Tomography (OPT). Applying this approach to the analysis of rodent models of MS, we provide global quantitative data of the major inflammatory component as a function of the clinical course. Our data demonstrates a strong correlation between the development and progression of neuroinflammation and clinical disease in several mouse and a rat model of MS refining the information regarding the spatial dynamics of the inflammatory component in EAE. This method provides a powerful tool to investigate the effect of environmental and genetic forces and for assessing the therapeutic effects of drug therapy in animal models of MS and other neuroinflammatory/neurodegenerative disorders. 相似文献
174.
Katayama Kazuhiro Hosui Atsushi Sakai Yoshiyuki Itou Minoru Matsuzaki Yasushi Takamori Yoriyuki Hosho Keiko Tsuru Tomomi Takikawa Yasuhiro Michitaka Kojiro Ogawa Eishin Miyoshi Yoko Ito Toshifumi Ida Shinobu Hamada Izumi Miyoshi Katsunori Kodama Hiroko Takehara Tetsuo 《Biological trace element research》2020,195(1):71-81
Biological Trace Element Research - The essential trace element zinc maintains liver functions. Liver diseases can alter overall zinc concentrations, and hypozincemia is associated with various... 相似文献
175.
176.
177.
Iben B. Bentsen Ida Nielsen Michael Lisby Helena B. Nielsen Souvik Sen Gupta Kamilla Mundbjerg Anni H. Andersen Lotte Bjergbaek 《Nucleic acids research》2013,41(5):3173-3189
To address how eukaryotic replication forks respond to fork stalling caused by strong non-covalent protein–DNA barriers, we engineered the controllable Fob-block system in Saccharomyces cerevisiae. This system allows us to strongly induce and control replication fork barriers (RFB) at their natural location within the rDNA. We discover a pivotal role for the MRX (Mre11, Rad50, Xrs2) complex for fork integrity at RFBs, which differs from its acknowledged function in double-strand break processing. Consequently, in the absence of the MRX complex, single-stranded DNA (ssDNA) accumulates at the rDNA. Based on this, we propose a model where the MRX complex specifically protects stalled forks at protein–DNA barriers, and its absence leads to processing resulting in ssDNA. To our surprise, this ssDNA does not trigger a checkpoint response. Intriguingly, however, placing RFBs ectopically on chromosome VI provokes a strong Rad53 checkpoint activation in the absence of Mre11. We demonstrate that proper checkpoint signalling within the rDNA is restored on deletion of SIR2. This suggests the surprising and novel concept that chromatin is an important player in checkpoint signalling. 相似文献
178.
?sa Segerstolpe Sander Granneman Petra Bj?rk Flavia de Lima Alves Juri Rappsilber Charlotta Andersson Martin H?gbom David Tollervey Lars Wieslander 《Nucleic acids research》2013,41(2):1178-1190
Ribosomal subunit biogenesis in eukaryotes is a complex multistep process. Mrd1 is an essential and conserved small (40S) ribosomal subunit synthesis factor that is required for early cleavages in the 35S pre-ribosomal RNA (rRNA). Yeast Mrd1 contains five RNA-binding domains (RBDs), all of which are necessary for optimal function of the protein. Proteomic data showed that Mrd1 is part of the early pre-ribosomal complexes, and deletion of individual RBDs perturbs the pre-ribosomal structure. In vivo ultraviolet cross-linking showed that Mrd1 binds to the pre-rRNA at two sites within the 18S region, in helix 27 (h27) and helix 28. The major binding site lies in h27, and mutational analyses shows that this interaction requires the RBD1-3 region of Mrd1. RBD2 plays the dominant role in h27 binding, but other RBDs also contribute directly. h27 and helix 28 are located close to the sequences that form the central pseudoknot, a key structural feature of the mature 40S subunit. We speculate that the modular structure of Mrd1 coordinates pseudoknot formation with pre-rRNA processing and subunit assembly. 相似文献
179.
Emmet McCormack Katherine J. Adams Namir J. Hassan Akhil Kotian Nikolai M. Lissin Malkit Sami Maja Mujić Tereza Osdal Bjørn Tore Gjertsen Deborah Baker Alex S. Powlesland Milos Aleksic Annelise Vuidepot Olivier Morteau Deborah H. Sutton Carl H. June Michael Kalos Rebecca Ashfield Bent K. Jakobsen 《Cancer immunology, immunotherapy : CII》2013,62(4):773-785
NY-ESO-1 and LAGE-1 are cancer testis antigens with an ideal profile for tumor immunotherapy, combining up-regulation in many cancer types with highly restricted expression in normal tissues and sharing a common HLA-A*0201 epitope, 157–165. Here, we present data to describe the specificity and anti-tumor activity of a bifunctional ImmTAC, comprising a soluble, high-affinity T-cell receptor (TCR) specific for NY-ESO-1157–165 fused to an anti-CD3 scFv. This reagent, ImmTAC-NYE, is shown to kill HLA-A2, antigen-positive tumor cell lines, and freshly isolated HLA-A2- and LAGE-1-positive NSCLC cells. Employing time-domain optical imaging, we demonstrate in vivo targeting of fluorescently labelled high-affinity NYESO-specific TCRs to HLA-A2-, NY-ESO-1157–165-positive tumors in xenografted mice. In vivo ImmTAC-NYE efficacy was tested in a tumor model in which human lymphocytes were stably co-engrafted into NSG mice harboring tumor xenografts; efficacy was observed in both tumor prevention and established tumor models using a GFP fluorescence readout. Quantitative RT-PCR was used to analyze the expression of both NY-ESO-1 and LAGE-1 antigens in 15 normal tissues, 5 cancer cell lines, 10 NSCLC, and 10 ovarian cancer samples. Overall, LAGE-1 RNA was expressed at a greater frequency and at higher levels than NY-ESO-1 in the tumor samples. These data support the clinical utility of ImmTAC-NYE as an immunotherapeutic agent for a variety of cancers. 相似文献
180.